Covid-19 Vaccines — Immunity, Variants, Boosters
Date Added: 
    September 8, 2022
      Journal/Publication: 
    The New England Journal of Medicine
      Publisher: 
    Massachusetts Medical Society
      Publication Date: 
    August 31, 2022
      Type: 
    Meta-analyses, Reviews, and Guidelines
      Format: 
    Article
      DOI (1): 
    10.1056/NEJMra2206573
      PMID (1): 
    36044620
      Abstract
The coronavirus disease 2019 (Covid-19) pandemic has claimed an estimated 15 million lives, including more than 1 million lives in the United States alone. The rapid development of multiple Covid-19 vaccines has been a triumph of biomedical research, and billions of vaccine doses have been administered worldwide. Challenges facing the Covid-19 vaccine field include inequitable vaccine distribution, vaccine hesitancy, waning immunity, and the emergence of highly transmissible viral variants that partially escape antibodies. This review summarizes the current state of knowledge about immune responses to Covid-19 vaccines and the importance of both humoral and cellular immunity for durable protection against severe disease.
Text Availability
Free full text
      
          
RPR Commentary
A summary of the current state of knowledge regarding COVID vaccines and emerging COVID variants. James W. Mold, MD, MPH